Skip to main content

Advertisement

SpringerLink
Log in

Link between obstructive sleep apnea and increased bone resorption in men

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

The bone metabolic abnormalities in patients with obstructive sleep apnea (OSA) were examined. Severity-dependent increases in the serum/urinary levels of bone resorption markers and their attenuation following continuous positive airway pressure therapy in subjects with OSA provide the first evidence of a link between OSA and abnormal bone metabolism.

Introduction

Hypoxia, microinflammation and oxidative stress, well-known pathophysiological features of obstructive sleep apnea (OSA), are also known to affect bone metabolism. We examined the bone metabolic abnormalities in patients with OSA and also the effects of continuous positive airway pressure (CPAP) therapy on these abnormalities.

Methods

A cross-sectional and prospective study was conducted in 50 consecutive male subjects visiting a sleep clinic and 15 age-matched control subjects without OSA. Plasma concentrations of IL-1β, IL-6, TNF-alfa, 3-nitrotyrosine, osteocalcin, bone-specific alkaline phosphatase (BAP), and urinary concentrations of cross-linked C-terminal telopeptide of type I collagen (CTX) were examined before and after 3 months’ CPAP in subjects with OSA.

Results

The plasma levels of the cytokines as well as the urinary CTX levels were higher in subjects with severe OSA than in those with mild OSA or control subjects. Significant decrease of the urinary excretion of CTX (before: 211 ± 107 vs. after: 128 ± 59 μg/mmol/creatinine; p < 0.01) as well as of the plasma levels of the cytokines was observed following 3 months’ CPAP.

Conclusions

Severity-dependent increases in the serum/urinary levels of bone resorption markers and their reversal following CPAP in subjects with OSA provide the first evidence of a link between OSA and abnormal bone metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Collop NA (2005) Obstructive sleep apnea syndromes. Semin Respir Crit Care Med 26:13–24

    Article  PubMed  Google Scholar 

  2. Caples SM, Gami AS, Somers VK (2005) Obstructive sleep apnea. Ann Intern Med 142:187–97

    PubMed  Google Scholar 

  3. Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:1906–1914

    Article  PubMed  CAS  Google Scholar 

  4. Hatipoglu U, Rubinstein I (2003) Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70:665–671

    Article  PubMed  Google Scholar 

  5. Schulz R, Mahmoudi S, Hattar K et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566–570

    PubMed  CAS  Google Scholar 

  6. Becker HF, Jerrentrup A, Ploch T et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68–73

    Article  PubMed  Google Scholar 

  7. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomised parallel trial. Lancet 359:204–210

    Article  PubMed  Google Scholar 

  8. Marin JM, Carrizo SJ, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053

    PubMed  Google Scholar 

  9. Doherty LS, Kiely JL, Swan V et al (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127:2076–2084

    Article  PubMed  Google Scholar 

  10. Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235

    Article  PubMed  CAS  Google Scholar 

  11. Papaioannou A, Parkinson W, Ferko N et al (2003) Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 14:913–917

    Article  PubMed  CAS  Google Scholar 

  12. Arnett TR, Gibbons DC, Utting JC et al (2003) Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 196:2–8

    Article  PubMed  CAS  Google Scholar 

  13. Basu S, Michaelsson K, Olofsson H et al (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288:275–279

    Article  PubMed  CAS  Google Scholar 

  14. Clowes JA, Riggs BL, Khosla S (2005) The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208:207–227

    Article  PubMed  CAS  Google Scholar 

  15. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325

    Article  PubMed  CAS  Google Scholar 

  16. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689

  17. Shiina K, Tomiyama H, Takata Y et al (2006) Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertens Res 29:433–441

    Article  PubMed  Google Scholar 

  18. Rechtshaffen AK, A (ed) 1968 A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects. UCLA Brain Information Service/Brain Research Institute, Los Angeles

  19. Chaudhary B, Dasti S, Park Y et al (1998) Hour-to-hour variability of oxygen saturation in sleep apnea. Chest 113:719–722

    Article  PubMed  CAS  Google Scholar 

  20. Sun YC, Chang PY, Tsao KC et al (2007) Establishment of a sandwich ELISA using commercial antibody for plasma or serum 3-nitrotyrosine (3NT). Elevation in inflammatory diseases and complementary between 3NT and myeloperoxidase. Clin Chim Acta 378:175–180

    Article  PubMed  CAS  Google Scholar 

  21. Utting JC, Robins SP, Brandao-Burch A et al (2006) Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res 312:1693–1702

    Article  PubMed  CAS  Google Scholar 

  22. Miller RG, Segal JB, Ashar BH et al (2006) High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol 81:236–241

    Article  PubMed  Google Scholar 

  23. Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:64s–75s

    Article  PubMed  CAS  Google Scholar 

  24. Mineo TC, Ambrogi V, Mineo D et al (2005) Bone mineral density improvement after lung volume reduction surgery for severe emphysema. Chest 127:1960–1966

    Article  PubMed  Google Scholar 

  25. Bonnick SL, Shulman L (2006) Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both. Am J Med 119:S25–31

    Article  PubMed  Google Scholar 

  26. Szulc P, Seeman E, Delmas PD (2000) Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11:281–294

    Article  PubMed  CAS  Google Scholar 

  27. Ueda M, Inaba M, Okuno S et al (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77:1130–1139

    Article  PubMed  CAS  Google Scholar 

  28. Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667

    Article  PubMed  CAS  Google Scholar 

  29. Alam I, Lewis K, Stephens JW, Baxter JN (2007) Obesity, metabolic syndrome and sleep apnea: all pro-inflammatory states. Obes Rev 8:119–127

    Article  PubMed  CAS  Google Scholar 

  30. Vgontzas AN, Pejovic S, Zoumakis E et al (2007) Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 92:4199–4207

    Article  PubMed  CAS  Google Scholar 

  31. Manelli F, Giustina A (2000) Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab. 11:79–85

    Article  PubMed  CAS  Google Scholar 

  32. Tanaka S, Nakamura K, Takahasi N et al (2005) Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 208:30–49

    Article  PubMed  CAS  Google Scholar 

  33. Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010–2018

    Article  PubMed  CAS  Google Scholar 

  34. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342

    Article  PubMed  CAS  Google Scholar 

  35. Rogers A, Eastell R (2005) Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 90:6323–6331

    Article  PubMed  CAS  Google Scholar 

  36. Bravo Mde L, Serpero LD, Barcelo A, Barbe F, Agusti A, Gozal D (2007) Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath 11:177–185

    Article  PubMed  Google Scholar 

  37. Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134

    Article  PubMed  CAS  Google Scholar 

  38. Tomlinson JW, Bujalska I, Stewart PM, Cooper MS (2000) The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocr Res 26:711–722

    Article  PubMed  CAS  Google Scholar 

  39. Fulkerson JA, Himes JH, French SA et al (2004) Bone outcomes and technical measurement issues of bone health among children and adolescents: considerations for nutrition and physical activity intervention trials. Osteoporos Int 15:929–941

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, Tokyo Medical University, 6–7–1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160–0023, Japan

    H. Tomiyama, K. Shiina, Y. Takata & A. Yamashina

  2. Third Department of Internal Medicine, Teikyo University Chiba Medical Center, Tokyo,  Japan

    R. Okazaki, D. Inoue & H. Ochiai

  3. Health Management and Policy, University of Tokyo Graduate School of Medicine, Tokyo, Japan

    H. Hashimoto

Authors
  1. H. Tomiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Okazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Ochiai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Shiina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. Takata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Yamashina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Yamashina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomiyama, H., Okazaki, R., Inoue, D. et al. Link between obstructive sleep apnea and increased bone resorption in men. Osteoporos Int 19, 1185–1192 (2008). https://doi.org/10.1007/s00198-007-0556-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-007-0556-0

Keywords

Search

Navigation